MJP Associates Inc. ADV decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 2.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,579 shares of the healthcare conglomerate’s stock after selling 61 shares during the quarter. UnitedHealth Group accounts for approximately 0.4% of MJP Associates Inc. ADV’s holdings, making the stock its 28th biggest position. MJP Associates Inc. ADV’s holdings in UnitedHealth Group were worth $1,324,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Advocacy Wealth Management Services LLC grew its stake in UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. boosted its stake in shares of UnitedHealth Group by 100.0% during the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 30 shares in the last quarter. Rise Advisors LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth about $38,000. Evolution Advisers Inc. bought a new stake in shares of UnitedHealth Group during the 1st quarter worth about $38,000. Finally, Cordant Inc. bought a new stake in shares of UnitedHealth Group during the 1st quarter worth about $45,000. Hedge funds and other institutional investors own 87.25% of the company’s stock.
Wall Street Analysts Forecast Growth
UNH has been the subject of several recent analyst reports. Sanford C. Bernstein downgraded UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price target for the company. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research report on Thursday, September 8th. Argus boosted their price objective on UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a research report on Monday, July 25th. Credit Suisse Group boosted their price objective on UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. Finally, Mizuho upped their price target on UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, August 10th. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $585.65.
Insider Buying and Selling at UnitedHealth Group
UnitedHealth Group Stock Down 0.4 %
NYSE UNH opened at $521.02 on Monday. The firm has a market cap of $487.35 billion, a PE ratio of 27.21, a price-to-earnings-growth ratio of 1.63 and a beta of 0.76. UnitedHealth Group Incorporated has a one year low of $383.12 and a one year high of $553.29. The stock’s 50 day simple moving average is $529.29 and its 200 day simple moving average is $511.81. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77.
UnitedHealth Group (NYSE:UNH – Get Rating) last released its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. The business had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. UnitedHealth Group’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same period in the prior year, the company earned $4.70 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th will be given a $1.65 dividend. The ex-dividend date of this dividend is Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a yield of 1.27%. UnitedHealth Group’s payout ratio is 34.46%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Kroger’s is Your One-Stop Consumer Staples Stock
- Adobe Perfects the Art of the Faceplant for Investors
- Tax Credits are the Incentives in the Inflation Reduction Act
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.